Immune to Cancer: The CRI Blog
-
Curtis Garbett’s Immunotherapy Story
Bladder Cancer | Diagnosed 2015 Advancing cancer research and visioning a future immune to bladder cancer Curtis’s Story… -
Cancer Immunotherapy: The Year in Review and a Look at the Year Ahead
Dr. Elizabeth Jaffee highlights 2018’s advances and 2019’s potential breakthroughs in cancer treatment
-
Learning from a Courageous Dog with Cancer
Francesca Pearson organized a Facebook fundraiser in memory of her dog Bosch.
-
How Immunotherapy Is Making an Impact in Liver Cancer
We spoke with Bruno Sangro, MD, PhD, about the current treatment landscape for patients with liver cancer,…
-
Six CRI-Funded Scientists on Dr. James P. Allison’s Impact on Their Lives and Careers
We spoke with six CRI-funded scientists who have worked in Allison’s lab about their experiences and the impact…
-
David’s Immunotherapy Story
Melanoma | Diagnosed 2014 I am not a statistic. David’s Story Melanoma, that word had always been terrifying… -
ASH18 Preview: Blood Cancer Immunotherapy Developments at 60th American Society of Hematology Meeting
The 2018 American Society of Hematology meeting will showcase a variety of basic and clinical advances in…
-
FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer
Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1…
-
Voices Amongst the Crowd at 2018 TCS New York City Marathon
Sixteen Team CRI runners ran the 26.2 mile 2018 TCS New York City Marathon and raised an…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.